Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

White, D., Schiller, G. J., Madan, S., Lentzsch, S., Chubar, E., Lavi, N., Van Domelen, D. R., Bentur, O. S., & Baljevic, M. (2024). Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Frontiers in Oncology, 14. https://doi.org/10.3389/fonc.2024.1352281

Authors:

Darrell White

Gary J Schiller

Sumit Madan

Suzanne Lentzsch

Evgeni Chubar

Noa Lavi

Dane R Van Domelen

Ohad S Bentur

Muhamed Baljevic

Affiliated Authors:

Suzanne Lentzsch